HEADER HYDROLASE (SERINE PROTEASE) 25-JAN-96 1FUJ TITLE PR3 (MYELOBLASTIN) COMPND MOL_ID: 1; COMPND 2 MOLECULE: PR3; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: MYELOBLASTIN; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: UNIDENTIFIED BACULOVIRUS; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 10469; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: BACULOVIRUS KEYWDS HYDROLASE, SERINE PROTEASE, GLYCOPROTEIN, ZYMOGEN, HYDROLASE (SERINE KEYWDS 2 PROTEASE) EXPDTA X-RAY DIFFRACTION AUTHOR M.FUJINAGA,M.M.CHERNAIA,R.HALENBECK,K.KOTHS,M.N.G.JAMES REVDAT 5 23-OCT-24 1FUJ 1 HETSYN REVDAT 4 29-JUL-20 1FUJ 1 COMPND REMARK SEQADV HETNAM REVDAT 4 2 1 LINK SITE ATOM REVDAT 3 13-JUL-11 1FUJ 1 VERSN REVDAT 2 24-FEB-09 1FUJ 1 VERSN REVDAT 1 11-JUL-96 1FUJ 0 JRNL AUTH M.FUJINAGA,M.M.CHERNAIA,R.HALENBECK,K.KOTHS,M.N.JAMES JRNL TITL THE CRYSTAL STRUCTURE OF PR3, A NEUTROPHIL SERINE PROTEINASE JRNL TITL 2 ANTIGEN OF WEGENER'S GRANULOMATOSIS ANTIBODIES. JRNL REF J.MOL.BIOL. V. 261 267 1996 JRNL REFN ISSN 0022-2836 JRNL PMID 8757293 JRNL DOI 10.1006/JMBI.1996.0458 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH W.BODE,A.Z.WEI,R.HUBER,E.MEYER,J.TRAVIS,S.NEUMANN REMARK 1 TITL X-RAY CRYSTAL STRUCTURE OF THE COMPLEX OF HUMAN LEUKOCYTE REMARK 1 TITL 2 ELASTASE (PMN ELASTASE) AND THE THIRD DOMAIN OF THE TURKEY REMARK 1 TITL 3 OVOMUCOID INHIBITOR REMARK 1 REF EMBO J. V. 5 2453 1986 REMARK 1 REFN ISSN 0261-4189 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : TNT REMARK 3 AUTHORS : TRONRUD,TEN EYCK,MATTHEWS REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.4 REMARK 3 NUMBER OF REFLECTIONS : 49712 REMARK 3 REMARK 3 USING DATA ABOVE SIGMA CUTOFF. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : NULL REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 USING ALL DATA, NO SIGMA CUTOFF. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.2010 REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6832 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 96 REMARK 3 SOLVENT ATOMS : 246 REMARK 3 REMARK 3 WILSON B VALUE (FROM FCALC, A**2) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. RMS WEIGHT COUNT REMARK 3 BOND LENGTHS (A) : 0.021 ; NULL ; NULL REMARK 3 BOND ANGLES (DEGREES) : 2.200 ; NULL ; NULL REMARK 3 TORSION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES (A) : 0.011 ; NULL ; NULL REMARK 3 GENERAL PLANES (A) : 0.015 ; NULL ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS (A**2) : NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS (A) : NULL ; NULL ; NULL REMARK 3 REMARK 3 INCORRECT CHIRAL-CENTERS (COUNT) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 RESTRAINT LIBRARIES. REMARK 3 STEREOCHEMISTRY : NULL REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1FUJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000173424. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : NULL REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 65602 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.980 REMARK 200 RESOLUTION RANGE LOW (A) : 68.700 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.48 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.70 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 27.03500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E, F, G, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 CG ASN A 159 C1 NAG E 1 2.19 REMARK 500 O6 NAG E 1 O5 FUC E 2 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 63C CA - CB - CG ANGL. DEV. = -15.9 DEGREES REMARK 500 LEU A 90 CA - CB - CG ANGL. DEV. = 17.9 DEGREES REMARK 500 ILE A 208 CG1 - CB - CG2 ANGL. DEV. = -13.8 DEGREES REMARK 500 PRO B 151 C - N - CD ANGL. DEV. = -15.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 61 30.29 -91.88 REMARK 500 HIS A 71 -68.43 -136.73 REMARK 500 ARG A 74 32.80 -94.38 REMARK 500 SER A 115 -152.89 -136.97 REMARK 500 PRO A 150 173.71 -47.83 REMARK 500 PHE A 184 147.89 -172.90 REMARK 500 TRP A 218 -61.08 74.19 REMARK 500 LEU A 223 -38.71 -130.93 REMARK 500 ARG B 27 56.38 -145.23 REMARK 500 PRO B 28 0.81 -56.04 REMARK 500 SER B 39 44.44 -67.13 REMARK 500 ASP B 61 -74.89 -71.41 REMARK 500 HIS B 71 -57.99 -140.61 REMARK 500 ASN B 92 78.19 -115.99 REMARK 500 ASP B 127 11.40 57.73 REMARK 500 HIS B 147 -37.20 -135.51 REMARK 500 PRO B 151 144.69 -18.07 REMARK 500 ARG B 186A 44.76 -109.73 REMARK 500 TRP B 218 -55.88 77.69 REMARK 500 HIS C 71 -60.04 -138.12 REMARK 500 SER C 115 -161.34 -113.76 REMARK 500 ALA C 146 -25.06 -35.12 REMARK 500 PRO C 150 -171.15 -68.90 REMARK 500 ARG C 186B 141.69 -178.31 REMARK 500 SER C 214 -71.17 -97.89 REMARK 500 TRP C 218 -48.22 71.70 REMARK 500 PRO D 28 2.66 -67.63 REMARK 500 SER D 39 46.70 -90.33 REMARK 500 HIS D 71 -55.67 -134.46 REMARK 500 ARG D 74 50.12 -102.84 REMARK 500 LEU D 114 99.09 -66.26 REMARK 500 SER D 115 -160.80 -120.93 REMARK 500 ALA D 146 -15.48 -48.17 REMARK 500 PRO D 151 -178.44 -50.39 REMARK 500 TRP D 218 -55.27 63.42 REMARK 500 REMARK 500 REMARK: NULL REMARK 999 REMARK 999 SEQUENCE REMARK 999 RESIDUE NUMBERING IS ACCORDING TO ALIGNMENT WITH REMARK 999 CHYMOTRYPSINOGEN. DBREF 1FUJ A 16 243 UNP P24158 PRN3_HUMAN 28 248 DBREF 1FUJ B 16 243 UNP P24158 PRN3_HUMAN 28 248 DBREF 1FUJ C 16 243 UNP P24158 PRN3_HUMAN 28 248 DBREF 1FUJ D 16 243 UNP P24158 PRN3_HUMAN 28 248 SEQADV 1FUJ ILE A 103 UNP P24158 VAL 119 CONFLICT SEQADV 1FUJ ILE B 103 UNP P24158 VAL 119 CONFLICT SEQADV 1FUJ ILE C 103 UNP P24158 VAL 119 CONFLICT SEQADV 1FUJ ILE D 103 UNP P24158 VAL 119 CONFLICT SEQRES 1 A 221 ILE VAL GLY GLY HIS GLU ALA GLN PRO HIS SER ARG PRO SEQRES 2 A 221 TYR MET ALA SER LEU GLN MET ARG GLY ASN PRO GLY SER SEQRES 3 A 221 HIS PHE CYS GLY GLY THR LEU ILE HIS PRO SER PHE VAL SEQRES 4 A 221 LEU THR ALA ALA HIS CYS LEU ARG ASP ILE PRO GLN ARG SEQRES 5 A 221 LEU VAL ASN VAL VAL LEU GLY ALA HIS ASN VAL ARG THR SEQRES 6 A 221 GLN GLU PRO THR GLN GLN HIS PHE SER VAL ALA GLN VAL SEQRES 7 A 221 PHE LEU ASN ASN TYR ASP ALA GLU ASN LYS LEU ASN ASP SEQRES 8 A 221 ILE LEU LEU ILE GLN LEU SER SER PRO ALA ASN LEU SER SEQRES 9 A 221 ALA SER VAL ALA THR VAL GLN LEU PRO GLN GLN ASP GLN SEQRES 10 A 221 PRO VAL PRO HIS GLY THR GLN CYS LEU ALA MET GLY TRP SEQRES 11 A 221 GLY ARG VAL GLY ALA HIS ASP PRO PRO ALA GLN VAL LEU SEQRES 12 A 221 GLN GLU LEU ASN VAL THR VAL VAL THR PHE PHE CYS ARG SEQRES 13 A 221 PRO HIS ASN ILE CYS THR PHE VAL PRO ARG ARG LYS ALA SEQRES 14 A 221 GLY ILE CYS PHE GLY ASP SER GLY GLY PRO LEU ILE CYS SEQRES 15 A 221 ASP GLY ILE ILE GLN GLY ILE ASP SER PHE VAL ILE TRP SEQRES 16 A 221 GLY CYS ALA THR ARG LEU PHE PRO ASP PHE PHE THR ARG SEQRES 17 A 221 VAL ALA LEU TYR VAL ASP TRP ILE ARG SER THR LEU ARG SEQRES 1 B 221 ILE VAL GLY GLY HIS GLU ALA GLN PRO HIS SER ARG PRO SEQRES 2 B 221 TYR MET ALA SER LEU GLN MET ARG GLY ASN PRO GLY SER SEQRES 3 B 221 HIS PHE CYS GLY GLY THR LEU ILE HIS PRO SER PHE VAL SEQRES 4 B 221 LEU THR ALA ALA HIS CYS LEU ARG ASP ILE PRO GLN ARG SEQRES 5 B 221 LEU VAL ASN VAL VAL LEU GLY ALA HIS ASN VAL ARG THR SEQRES 6 B 221 GLN GLU PRO THR GLN GLN HIS PHE SER VAL ALA GLN VAL SEQRES 7 B 221 PHE LEU ASN ASN TYR ASP ALA GLU ASN LYS LEU ASN ASP SEQRES 8 B 221 ILE LEU LEU ILE GLN LEU SER SER PRO ALA ASN LEU SER SEQRES 9 B 221 ALA SER VAL ALA THR VAL GLN LEU PRO GLN GLN ASP GLN SEQRES 10 B 221 PRO VAL PRO HIS GLY THR GLN CYS LEU ALA MET GLY TRP SEQRES 11 B 221 GLY ARG VAL GLY ALA HIS ASP PRO PRO ALA GLN VAL LEU SEQRES 12 B 221 GLN GLU LEU ASN VAL THR VAL VAL THR PHE PHE CYS ARG SEQRES 13 B 221 PRO HIS ASN ILE CYS THR PHE VAL PRO ARG ARG LYS ALA SEQRES 14 B 221 GLY ILE CYS PHE GLY ASP SER GLY GLY PRO LEU ILE CYS SEQRES 15 B 221 ASP GLY ILE ILE GLN GLY ILE ASP SER PHE VAL ILE TRP SEQRES 16 B 221 GLY CYS ALA THR ARG LEU PHE PRO ASP PHE PHE THR ARG SEQRES 17 B 221 VAL ALA LEU TYR VAL ASP TRP ILE ARG SER THR LEU ARG SEQRES 1 C 221 ILE VAL GLY GLY HIS GLU ALA GLN PRO HIS SER ARG PRO SEQRES 2 C 221 TYR MET ALA SER LEU GLN MET ARG GLY ASN PRO GLY SER SEQRES 3 C 221 HIS PHE CYS GLY GLY THR LEU ILE HIS PRO SER PHE VAL SEQRES 4 C 221 LEU THR ALA ALA HIS CYS LEU ARG ASP ILE PRO GLN ARG SEQRES 5 C 221 LEU VAL ASN VAL VAL LEU GLY ALA HIS ASN VAL ARG THR SEQRES 6 C 221 GLN GLU PRO THR GLN GLN HIS PHE SER VAL ALA GLN VAL SEQRES 7 C 221 PHE LEU ASN ASN TYR ASP ALA GLU ASN LYS LEU ASN ASP SEQRES 8 C 221 ILE LEU LEU ILE GLN LEU SER SER PRO ALA ASN LEU SER SEQRES 9 C 221 ALA SER VAL ALA THR VAL GLN LEU PRO GLN GLN ASP GLN SEQRES 10 C 221 PRO VAL PRO HIS GLY THR GLN CYS LEU ALA MET GLY TRP SEQRES 11 C 221 GLY ARG VAL GLY ALA HIS ASP PRO PRO ALA GLN VAL LEU SEQRES 12 C 221 GLN GLU LEU ASN VAL THR VAL VAL THR PHE PHE CYS ARG SEQRES 13 C 221 PRO HIS ASN ILE CYS THR PHE VAL PRO ARG ARG LYS ALA SEQRES 14 C 221 GLY ILE CYS PHE GLY ASP SER GLY GLY PRO LEU ILE CYS SEQRES 15 C 221 ASP GLY ILE ILE GLN GLY ILE ASP SER PHE VAL ILE TRP SEQRES 16 C 221 GLY CYS ALA THR ARG LEU PHE PRO ASP PHE PHE THR ARG SEQRES 17 C 221 VAL ALA LEU TYR VAL ASP TRP ILE ARG SER THR LEU ARG SEQRES 1 D 221 ILE VAL GLY GLY HIS GLU ALA GLN PRO HIS SER ARG PRO SEQRES 2 D 221 TYR MET ALA SER LEU GLN MET ARG GLY ASN PRO GLY SER SEQRES 3 D 221 HIS PHE CYS GLY GLY THR LEU ILE HIS PRO SER PHE VAL SEQRES 4 D 221 LEU THR ALA ALA HIS CYS LEU ARG ASP ILE PRO GLN ARG SEQRES 5 D 221 LEU VAL ASN VAL VAL LEU GLY ALA HIS ASN VAL ARG THR SEQRES 6 D 221 GLN GLU PRO THR GLN GLN HIS PHE SER VAL ALA GLN VAL SEQRES 7 D 221 PHE LEU ASN ASN TYR ASP ALA GLU ASN LYS LEU ASN ASP SEQRES 8 D 221 ILE LEU LEU ILE GLN LEU SER SER PRO ALA ASN LEU SER SEQRES 9 D 221 ALA SER VAL ALA THR VAL GLN LEU PRO GLN GLN ASP GLN SEQRES 10 D 221 PRO VAL PRO HIS GLY THR GLN CYS LEU ALA MET GLY TRP SEQRES 11 D 221 GLY ARG VAL GLY ALA HIS ASP PRO PRO ALA GLN VAL LEU SEQRES 12 D 221 GLN GLU LEU ASN VAL THR VAL VAL THR PHE PHE CYS ARG SEQRES 13 D 221 PRO HIS ASN ILE CYS THR PHE VAL PRO ARG ARG LYS ALA SEQRES 14 D 221 GLY ILE CYS PHE GLY ASP SER GLY GLY PRO LEU ILE CYS SEQRES 15 D 221 ASP GLY ILE ILE GLN GLY ILE ASP SER PHE VAL ILE TRP SEQRES 16 D 221 GLY CYS ALA THR ARG LEU PHE PRO ASP PHE PHE THR ARG SEQRES 17 D 221 VAL ALA LEU TYR VAL ASP TRP ILE ARG SER THR LEU ARG MODRES 1FUJ ASN A 159 ASN GLYCOSYLATION SITE MODRES 1FUJ ASN B 159 ASN GLYCOSYLATION SITE MODRES 1FUJ ASN C 159 ASN GLYCOSYLATION SITE MODRES 1FUJ ASN D 159 ASN GLYCOSYLATION SITE HET NAG E 1 14 HET FUC E 2 10 HET NAG F 1 14 HET FUC F 2 10 HET NAG G 1 14 HET FUC G 2 10 HET NAG H 1 14 HET FUC H 2 10 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L- HETSYN 2 FUC FUCOSE; FUCOSE FORMUL 5 NAG 4(C8 H15 N O6) FORMUL 5 FUC 4(C6 H12 O5) FORMUL 9 HOH *246(H2 O) HELIX 1 1 ALA A 56 LEU A 59 5 4 HELIX 2 2 GLN A 63A LEU A 63C 5 3 HELIX 3 3 VAL A 231 LEU A 242 5 12 HELIX 4 4 GLN B 63A LEU B 63C 5 3 HELIX 5 5 VAL B 231 THR B 241 5 11 HELIX 6 6 ALA C 56 CYS C 58 5 3 HELIX 7 7 GLN C 63A LEU C 63C 5 3 HELIX 8 8 VAL C 231 LEU C 242 5 12 HELIX 9 9 GLN D 63A LEU D 63C 5 3 HELIX 10 10 VAL D 231 THR D 241 5 11 SHEET 1 A 7 GLN A 81 SER A 84 0 SHEET 2 A 7 VAL A 64 LEU A 68 -1 N LEU A 68 O GLN A 81 SHEET 3 A 7 MET A 30 MET A 35 -1 N GLN A 34 O ASN A 65 SHEET 4 A 7 CYS A 42 HIS A 48 -1 N GLY A 44 O ALA A 31 SHEET 5 A 7 PHE A 51 THR A 54 -1 N LEU A 53 O THR A 45 SHEET 6 A 7 LEU A 104 LEU A 108 -1 N ILE A 106 O VAL A 52 SHEET 7 A 7 VAL A 85 LEU A 90 -1 N PHE A 89 O LEU A 105 SHEET 1 B 6 GLN A 135 GLY A 140 0 SHEET 2 B 6 GLN A 156 VAL A 163 -1 N VAL A 160 O CYS A 136 SHEET 3 B 6 ASN A 180 PHE A 184 -1 N PHE A 184 O THR A 161 SHEET 4 B 6 ASP A 226 ARG A 230 -1 N PHE A 228 O ILE A 181 SHEET 5 B 6 ILE A 208 PHE A 215 -1 N PHE A 215 O PHE A 227 SHEET 6 B 6 PRO A 198 CYS A 201 -1 N CYS A 201 O ILE A 208 SHEET 1 C 7 GLN B 81 SER B 84 0 SHEET 2 C 7 VAL B 64 LEU B 68 -1 N LEU B 68 O GLN B 81 SHEET 3 C 7 MET B 30 MET B 35 -1 N GLN B 34 O ASN B 65 SHEET 4 C 7 CYS B 42 HIS B 48 -1 N GLY B 44 O ALA B 31 SHEET 5 C 7 PHE B 51 THR B 54 -1 N LEU B 53 O THR B 45 SHEET 6 C 7 LEU B 104 LEU B 108 -1 N ILE B 106 O VAL B 52 SHEET 7 C 7 VAL B 85 LEU B 90 -1 N PHE B 89 O LEU B 105 SHEET 1 D 6 GLN B 135 GLY B 140 0 SHEET 2 D 6 GLN B 156 VAL B 163 -1 N VAL B 160 O CYS B 136 SHEET 3 D 6 ASN B 180 PHE B 184 -1 N PHE B 184 O THR B 161 SHEET 4 D 6 ASP B 226 ARG B 230 -1 N PHE B 228 O ILE B 181 SHEET 5 D 6 ILE B 208 PHE B 215 -1 N PHE B 215 O PHE B 227 SHEET 6 D 6 PRO B 198 CYS B 201 -1 N CYS B 201 O ILE B 208 SHEET 1 E 4 GLN C 81 SER C 84 0 SHEET 2 E 4 VAL C 64 LEU C 68 -1 N LEU C 68 O GLN C 81 SHEET 3 E 4 MET C 30 MET C 35 -1 N GLN C 34 O ASN C 65 SHEET 4 E 4 HIS C 40 THR C 45 -1 N GLY C 44 O ALA C 31 SHEET 1 F 3 PHE C 51 THR C 54 0 SHEET 2 F 3 LEU C 104 LEU C 108 -1 N ILE C 106 O VAL C 52 SHEET 3 F 3 VAL C 85 LEU C 90 -1 N PHE C 89 O LEU C 105 SHEET 1 G 6 GLN C 135 GLY C 140 0 SHEET 2 G 6 GLN C 156 VAL C 163 -1 N VAL C 160 O CYS C 136 SHEET 3 G 6 ASN C 180 PHE C 184 -1 N PHE C 184 O THR C 161 SHEET 4 G 6 ASP C 226 ARG C 230 -1 N PHE C 228 O ILE C 181 SHEET 5 G 6 ILE C 208 VAL C 216 -1 N PHE C 215 O PHE C 227 SHEET 6 G 6 PRO C 198 CYS C 201 -1 N CYS C 201 O ILE C 208 SHEET 1 H 4 CYS D 42 THR D 45 0 SHEET 2 H 4 MET D 30 MET D 35 -1 N LEU D 33 O CYS D 42 SHEET 3 H 4 VAL D 64 LEU D 68 -1 N VAL D 67 O SER D 32 SHEET 4 H 4 GLN D 81 SER D 84 -1 N PHE D 83 O VAL D 66 SHEET 1 I 3 PHE D 51 THR D 54 0 SHEET 2 I 3 LEU D 104 LEU D 108 -1 N ILE D 106 O VAL D 52 SHEET 3 I 3 VAL D 85 LEU D 90 -1 N PHE D 89 O LEU D 105 SHEET 1 J 6 GLN D 135 GLY D 140 0 SHEET 2 J 6 GLN D 156 VAL D 163 -1 N VAL D 160 O CYS D 136 SHEET 3 J 6 ASN D 180 PHE D 184 -1 N PHE D 184 O THR D 161 SHEET 4 J 6 ASP D 226 ARG D 230 -1 N PHE D 228 O ILE D 181 SHEET 5 J 6 ILE D 208 PHE D 215 -1 N PHE D 215 O PHE D 227 SHEET 6 J 6 PRO D 198 CYS D 201 -1 N CYS D 201 O ILE D 208 SSBOND 1 CYS A 42 CYS A 58 1555 1555 2.01 SSBOND 2 CYS A 136 CYS A 201 1555 1555 2.02 SSBOND 3 CYS A 168 CYS A 182 1555 1555 2.02 SSBOND 4 CYS A 191 CYS A 220 1555 1555 2.03 SSBOND 5 CYS B 42 CYS B 58 1555 1555 2.01 SSBOND 6 CYS B 136 CYS B 201 1555 1555 2.02 SSBOND 7 CYS B 168 CYS B 182 1555 1555 2.02 SSBOND 8 CYS B 191 CYS B 220 1555 1555 2.03 SSBOND 9 CYS C 42 CYS C 58 1555 1555 2.01 SSBOND 10 CYS C 136 CYS C 201 1555 1555 2.01 SSBOND 11 CYS C 168 CYS C 182 1555 1555 2.01 SSBOND 12 CYS C 191 CYS C 220 1555 1555 2.03 SSBOND 13 CYS D 42 CYS D 58 1555 1555 2.01 SSBOND 14 CYS D 136 CYS D 201 1555 1555 2.02 SSBOND 15 CYS D 168 CYS D 182 1555 1555 2.01 SSBOND 16 CYS D 191 CYS D 220 1555 1555 2.03 LINK ND2 ASN A 159 C1 NAG E 1 1555 1555 1.36 LINK ND2 ASN B 159 C1 NAG F 1 1555 1555 1.40 LINK ND2 ASN C 159 C1 NAG G 1 1555 1555 1.38 LINK ND2 ASN D 159 C1 NAG H 1 1555 1555 1.37 LINK O6 NAG E 1 C1 FUC E 2 1555 1555 1.36 LINK O6 NAG F 1 C1 FUC F 2 1555 1555 1.40 LINK O6 NAG G 1 C1 FUC G 2 1555 1555 1.40 LINK O6 NAG H 1 C1 FUC H 2 1555 1555 1.39 CRYST1 85.603 54.070 113.506 90.00 90.69 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011682 0.000000 0.000141 0.00000 SCALE2 0.000000 0.018495 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008811 0.00000